Literature DB >> 8534503

The human immune response to hepatitis B surface antigen.

C A Alper1.   

Abstract

The anti-HBs response is bimodal with 4.2% of healthy persons producing no antibody and an additional 10% being hyporesponders. In the study of nonresponders, 2 extended haplotypes, [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7], were found to be enriched in a pattern suggesting recessive inheritance. In the prospective immunization of homozygotes and heterozygotes for [HLA-B8, SC01, DR3], the homozygotes had less antibody than the heterozygotes. Family studies confirmed that the anti-HBs response was dominant and MHC linked, whereas nonresponse was recessive. In studies in vitro, it was shown that nonresponders failed to show lymphoproliferation in response to hepatitis B surface antigen (HBsAg) or an immunodominant nonapeptide. The lymphoproliferative response of responders to these stimuli was comparable and inhibited by anti-DR but not antibody to DQ or DP. The removal of CD8+ T cells did not produce lymphoproliferation to HBsAg in nonresponders. From mixtures of antigen-presenting cells and T cells from MHC-identical response discordant pairs, it was shown that the defect in the nonresponders was in their T cells and not their antigen-presenting cells, ruling out defective MHC binding or antigen processing as the basis of nonresponse.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534503     DOI: 10.1159/000424869

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  12 in total

1.  Efficacy of Hepatitis B Vaccination among Children in Special Region of Yogyakarta, Indonesia: Evaluation of Humoral and Cellular Immunity.

Authors:  Caessar Pronocitro; Nenny Sri Mulyani; Afif Avicenna Ghufron; Yugata Halimawan Hazazi; Bambang Ardianto; Didik Setyo Heriyanto
Journal:  Kobe J Med Sci       Date:  2018-01-17

2.  Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.

Authors:  A Kruger; P Adams; J Hammer; W O Böcher; P M Schneider; C Rittner; T Hoehler
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.

Authors:  Azam Roohi; Yaghoub Yazdani; Jalal Khoshnoodi; Seyed Mohammad Jazayeri; William F Carman; Mahmood Chamankhah; Manley Rashedan; Fazel Shokri
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 4.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 5.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 6.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 7.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

Review 8.  Vaccination in the elderly: an immunological perspective.

Authors:  Wilbur H Chen; Bernard F Kozlovsky; Rita B Effros; Beatrix Grubeck-Loebenstein; Robert Edelman; Marcelo B Sztein
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

9.  Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.

Authors:  Kelli K Ryckman; Katherine Fielding; Adrian V Hill; Maimuna Mendy; Pura Rayco-Solon; Giorgio Sirugo; Marianne A van der Sande; Pauline Waight; Hilton C Whittle; Andrew J Hall; Scott M Williams; Branwen J Hennig
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

10.  Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.

Authors:  Huaibin Zou; Yu Chen; Zhongping Duan; Hua Zhang
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.